The mechanisms involved in these pro-angiogenic activities were probed in vitro using a breast cancer cell line, (MCF-7), stably infected with the HMGB1 gene and combined with siRNA technology and assays of protein expression and cell migration [158]. This evidence concerns the gene HMGB1 and breast carcinoma.